| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 30, 2021 |
| Accession Number: | 0001193125-21-367548 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 30, 2021 |
| Accession Number: | 0001193125-21-367548 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/9/2021 | $28.00 → $38.25 | Buy → Neutral | Chardan Capital |
| 11/19/2021 | $30.00 → $38.25 | Outperform → Sector Perform | RBC Capital |
| 11/18/2021 | $32.00 → $38.25 | Buy → Neutral | HC Wainwright & Co. |
| 8/11/2021 | $36.00 → $25.00 | Buy → Neutral | Goldman Sachs |
| 8/10/2021 | $34.00 → $28.00 | Buy | Chardan Capital |
| 8/10/2021 | $38.00 → $32.00 | Buy | HC Wainwright & Co. |
| 8/9/2021 | $32.00 | Buy → Neutral | Citigroup |
| 8/6/2021 | $35.00 → $30.00 | Outperform | RBC Capital |